Peritoneal instillation of taurolidine or polihexanide modulates intestinal microcirculation in experimental endotoxemia

[1]  Stephan Rogalla,et al.  High doses of taurolidine inhibit advanced intraperitoneal tumor growth in rats. , 2005, The Journal of surgical research.

[2]  C. Braumann,et al.  Taurolidine–a new drug with anti-tumor and anti-angiogenic effects , 2005, Anti-cancer drugs.

[3]  H. Frieling,et al.  Intraperitoneal instillation of polihexanide produces hypotension and vasodilation: in vivo and in vitro study in rats , 2005, International Journal of Colorectal Disease.

[4]  Ayhan Cevik,et al.  Effect of Peritoneal Lavage with Taurolidine on Primary Colonic Anastomosis in a Rat Model of Secondary Peritonitis , 2006, Surgery Today.

[5]  M. Brock,et al.  Treatment of glioblastoma with intravenous taurolidine. First clinical experience. , 2004, Anticancer research.

[6]  Andriessen Consultants.  Konsensusempfehlung zur Auswahl von Wirkstoffen für die Wundantiseptik , 2004 .

[7]  S. Ziemer,et al.  Effects of C1 esterase inhibitor administration on intestinal functional capillary density, leukocyte adherence and mesenteric plasma extravasation during experimental endotoxemia , 2004, Intensive Care Medicine.

[8]  T. Abraham,et al.  Myocardial contractility by strain echocardiography: comparison with physiological measurements in an in vitro model. , 2003, American journal of physiology. Heart and circulatory physiology.

[9]  S. Pulletz,et al.  Sympathetic modulation of intestinal microvascular blood flow oscillations in experimental endotoxemia. , 2003, Clinical hemorheology and microcirculation.

[10]  M. Weigand,et al.  [Clinical management of patients with sepsis]. , 2003, Der Anaesthesist.

[11]  B. Böttiger,et al.  Klinisches Management bei Patienten mit Sepsis , 2003, Der Anaesthesist.

[12]  H. Goor.  Interventional management of abdominal sepsis: when and how , 2002, Langenbeck's Archives of Surgery.

[13]  C. Sprung,et al.  Definition of sepsis , 2001, Intensive Care Medicine.

[14]  H. Kock,et al.  Wirksamkeit eines neuartigen Antisepticum in der Behandlung kontaminierter Weichteilwunden , 2001, Der Chirurg.

[15]  Christoph Abels,et al.  Characterization and prevention of phototoxic effects in intravital fluorescence microscopy in the hamster dorsal skinfold model , 2000, Langenbeck's Archives of Surgery.

[16]  L. Frey,et al.  Bedeutung der Perfusion des Gastrointestinaltrakts im Schock , 2000, Der Anaesthesist.

[17]  L. Frey,et al.  [Significance of perfusion of the gastrointestinal tract in shock]. , 2000, Der Anaesthesist.

[18]  D. Escande,et al.  Interspecies differences in the cardiac negative inotropic effects of beta(3)-adrenoceptor agonists. , 1999, The Journal of pharmacology and experimental therapeutics.

[19]  E. Martin,et al.  Influence of epinephrine and norepinephrine on intestinal villous blood flow during endotoxemia. , 1999, Journal of critical care.

[20]  W. Sibbald,et al.  Dopexamine attenuates flow motion in ileal mucosal arterioles in normotensive sepsis. , 1999, Critical care medicine.

[21]  H. Buhr,et al.  Does microcirculation play a role in the pathogenesis of inflammatory bowel diseases? Answers from intravital microscopic studies in animal models , 1999, International Journal of Colorectal Disease.

[22]  M. Gründling,et al.  [Acute failure of the intestinal barrier--pathophysiology, diagnosis, prophylaxis and therapy]. , 1999, Anaesthesiologie und Reanimation.

[23]  L. J. Chandler,et al.  Cardiac impairment and nitric oxide synthase activity in the chronic portal vein-stenosed rat. , 1999, The American journal of physiology.

[24]  W. Sibbald,et al.  SELECTIVE GUT MICROCIRCULATORY CONTROL (SGMC) IN SEPTIC RATS: A NOVEL APPROACH WITH A LOCALLY APPLIED VASOACTIVE DRUG , 1998, Shock.

[25]  A. Kramer,et al.  Explantationstest mit Haut und Peritoneum der neonatalen Ratte als Voraussagetest zur Verträglichkeit lokaler Antiinfektiva für Wunden und Körperhöhlen , 1998, Der Chirurg.

[26]  D. Berger,et al.  Management of abdominal sepsis , 1998, Langenbeck's Archives of Surgery.

[27]  E. Martin,et al.  Dobutamine maintains intestinal villus blood flow during normotensive endotoxemia: an intravital microscopic study in the rat. , 1997, Journal of critical care.

[28]  W. Uhl,et al.  Chirurgische Therapie der diffusen Peritonitis: Herdsanierung und intraoperative extensive Lavage , 1997, Der Chirurg.

[29]  K. Staubach.  Adjuvante Peritonitistherapie mit Taurolidin Modulation der Mediatorfreisetzung , 1996, Langenbecks Archiv für Chirurgie.

[30]  G. Görtz.  Lokale antiseptische und antiendotoxische Maßnahmen bei intraabdominalen Infektionen , 1996, Langenbecks Archiv für Chirurgie.

[31]  Reith Hb.  Therapy of peritonitis today. Surgical management and adjuvant therapy strategies , 1997 .

[32]  Staubach Kh.  Adjuvant therapy of peritonitis with taurolidine. Modulation of mediator liberation , 1997 .

[33]  G. Görtz.  [Local antiseptic and anti-endotoxin measures in intra-abdominal infections]. , 1997, Langenbecks Archiv fur Chirurgie.

[34]  K. Staubach.  [Adjuvant therapy of peritonitis with taurolidine. Modulation of mediator liberation]. , 1997, Langenbecks Archiv fur Chirurgie.

[35]  E. Martin,et al.  Effect of endotoxemia on intestinal villus microcirculation in rats. , 1996, The Journal of surgical research.

[36]  W. Sibbald,et al.  Decreased capillary density in vivo in bowel mucosa of rats with normotensive sepsis. , 1996, The Journal of surgical research.

[37]  S. Willatts,et al.  Effect of the antiendotoxic agent, taurolidine, in the treatment of sepsis syndrome: a placebo-controlled, double-blind trial. , 1995, Critical care medicine.

[38]  R. Reding,et al.  Taurolidine peritoneal lavage as prophylaxis against infection after elective colorectal surgery , 1995, The British journal of surgery.

[39]  M. Wilson,et al.  Microvascular vasoconstriction and mucosal hypoperfusion of the rat small intestine during bacteremia. , 1993, Circulatory shock.

[40]  J. Blenkharn.  In‐vitro antibacterial activity of noxythiolin and taurolidine , 1990, The Journal of pharmacy and pharmacology.

[41]  S. Gorman,et al.  A COMPARATIVE STUDY OF THE MICROBIAL ANTI‐ADHERENCE CAPACITIES OF THREE ANTIMICROBIAL AGENTS , 1987, Journal of clinical pharmacy and therapeutics.

[42]  S. Gorman,et al.  Reduced adherence of micro-organisms to human mucosal epithelial cells following treatment with Taurolin, a novel antimicrobial agent. , 1987, The Journal of applied bacteriology.

[43]  M. Linder,et al.  [Drug therapy of peritonitis. 6-year experience with the chemotherapeutic agent and anti-endotoxin taurolin]. , 1983, Fortschritte der Medizin.

[44]  Browne Mk.  The treatment of peritonitis by an antiseptic - taurolin. , 1981 .

[45]  M. K. Browne.  The treatment of peritonitis by an antiseptic - taurolin. , 1981, Pharmatherapeutica.

[46]  G. Leslie,et al.  The anti-endotoxin activity of Taurolin in experimental animals. , 1979, The Journal of applied bacteriology.

[47]  M. K. Browne,et al.  C controlled trial of taurolin in established bacterial peritonitis. , 1978, Surgery, gynecology & obstetrics.

[48]  B. Zweifach,et al.  The application of stereological principles to morphometry of the microcirculation in different tissues. , 1977, Microvascular research.